Jeffrey Henderson W.'s most recent trade in Halozyme Therapeutics Inc. was a trade of 5,750 Option to Purchase Common Stock done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 5,750 | 5,750 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 4,165 | 32,776 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 60.34 per share. | 28 Apr 2025 | 4,297 | 28,811 (0%) | 0% | 60.3 | 259,268 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 28 Apr 2025 | 200 | 28,611 (0%) | 0% | 61.0 | 12,199 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 64.05 per share. | 01 Apr 2025 | 503 | 33,108 (0%) | 0% | 64.0 | 32,217 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 2,097 | 10,406 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 1,901 | 3,938 | - | - | Deferred Stock Unit | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 1,901 | 8,309 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 59.12 per share. | 03 Mar 2025 | 3,205 | 33,611 (0%) | 0% | 59.1 | 189,467 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 57.93 per share. | 03 Mar 2025 | 1,795 | 36,816 (0%) | 0% | 57.9 | 103,992 | Common Stock |
| Becton, Dickinson & Company | Jeffrey W. Henderson | Director | Purchase of securities on an exchange or from another person at price $ 233.62 per share. | 10 Feb 2025 | 1,500 | 8,015 (0%) | 0% | 233.6 | 350,430 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 56.41 per share. | 03 Feb 2025 | 3,900 | 38,611 (0%) | 0% | 56.4 | 219,980 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 55.94 per share. | 03 Feb 2025 | 1,100 | 42,511 (0%) | 0% | 55.9 | 61,537 | Common Stock |
| Becton, Dickinson & Company | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 6,515 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 06 Jan 2025 | 10,000 | 43,611 (0%) | 0% | 50.0 | 500,060 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 8,804 | 8,804 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 6,501 | 53,611 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 2,056 | 6,408 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 2,056 | 5,726 | - | - | Deferred Stock Unit | |
| QUALCOMM | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 1,624 | 7,772 | - | - | Deferred Stock Unit | |
| Becton, Dickinson & Company | Jeffrey Henderson W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 5,568 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Jeffrey W. Henderson | Director | 04 Aug 2023 | 2,000 | 30,866 (0%) | 0% | 1.9 | 3,820 | Common Stock | |
| FibroGen Inc | Jeffrey W. Henderson | Director | 11 Jul 2023 | 2,000 | 32,866 (0%) | 0% | 2.7 | 5,380 | Common Stock | |
| FibroGen Inc | Jeffrey W. Henderson | Director | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Jeffrey W. Henderson | Director | 07 Jun 2023 | 8,289 | 41,866 (0%) | 0% | 0 | Common Stock | ||
| FibroGen Inc | Jeffrey W. Henderson | Director | 07 Jun 2023 | 4,994 | 34,866 (0%) | 0% | 17.7 | 88,344 | Common Stock | |
| FibroGen Inc | Jeffrey W. Henderson | Director | 07 Jun 2023 | 2,006 | 39,860 (0%) | 0% | 16.9 | 33,841 | Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 11,371 | 11,371 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 8,065 | 47,110 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,316 | 5,421 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,316 | 6,004 | - | - | Deferred Stock Unit | |
| QUALCOMM | Jeffrey W. Henderson | Director | Sale or transfer of securities back to the company at price $ 115.19 per share. | 10 Mar 2023 | 1,069 | 4,352 (0%) | 0% | 115.2 | 123,138 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 2,203 | 9,301 | - | - | Deferred Stock Unit | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 48.51 per share. | 28 Feb 2023 | 10,000 | 49,045 (0%) | 0% | 48.5 | 485,100 | Common Stock |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 47.71 per share. | 28 Feb 2023 | 10,000 | 39,045 (0%) | 0% | 47.7 | 477,100 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 124.19 per share. | 22 Feb 2023 | 2,500 | 2,105 (0%) | 0% | 124.2 | 310,469 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 124.05 per share. | 22 Feb 2023 | 2,500 | 4,605 (0%) | 0% | 124.1 | 310,132 | Common Stock |
| Becton, Dickinson & Company | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 4,653 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Jeffrey W. Henderson | Director | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Jeffrey W. Henderson | Director | 16 Jun 2022 | 15,777 | 33,577 (0%) | 0% | 0 | Common Stock | ||
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 4,559 | 6,944 | - | - | Deferred Stock Unit | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 4,559 | 8,574 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Sale or transfer of securities back to the company at price $ 152.34 per share. | 12 Mar 2022 | 1,469 | 7,105 (0%) | 0% | 152.3 | 223,787 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 1,774 | 11,485 | - | - | Deferred Stock Unit | |
| Becton, Dickinson & Company | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 3,777 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Jeffrey W. Henderson | Director | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Jeffrey W. Henderson | Director | 26 May 2021 | 4,700 | 17,800 (0%) | 0% | 0 | Common Stock | ||
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 5,230 | 52,839 | - | 0 | Restricted Stock Units | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 4,134 | 5,348 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Jeffrey W. Henderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2021 | 4,134 | 9,578 | - | - | Deferred Stock Unit | |
| QUALCOMM | Jeffrey W. Henderson | Director | Sale or transfer of securities back to the company at price $ 140.33 per share. | 05 Apr 2021 | 1,333 | 4,015 (0%) | 0% | 140.3 | 187,060 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 1,922 | 13,653 | - | - | Deferred Stock Unit | |
| Becton, Dickinson & Company | Jeffrey W. Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 2,918 (0%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 40.07 per share. | 25 Nov 2020 | 24,498 | 47,609 (0%) | 0% | 40.1 | 981,757 | Common Stock |
| QUALCOMM | Jeffrey W. Henderson | Director | Sale of securities on an exchange or to another person at price $ 141.10 per share. | 10 Nov 2020 | 6,000 | 1,214 (0%) | 0% | 141.1 | 846,602 | Common Stock |